title: Retraction notice to: PS124-Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (PSC) in Individuals with Inflammatory Bowel Disease [J Hepatol 64 (2016) S199].
authors.affiliation: University of Calgary, Calgary, Canada.
authors.forename: B
authors.initials: B
authors.lastname: Eksteen
authors.affiliation: Alberta Health Services, Calgary, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Heatherington
authors.affiliation: University of Calgary, Calgary, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Oshiomogo
authors.affiliation: University of Calgary, Calgary, Canada.
authors.forename: R
authors.initials: R
authors.lastname: Panaccione
authors.affiliation: University of Calgary, Calgary, Canada.
authors.forename: G
authors.initials: G
authors.lastname: Kaplan
authors.affiliation: University of Calgary, Calgary, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Ghosh